World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
13617
World Ranking
3036
National Ranking
204

Ralf Gold publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ralf Gold sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 159 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ralf Gold D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ralf Gold sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ralf Gold is affiliated with Ruhr University Bochum in Germany and specializes in Medicine, with a prominent focus on Neurology. Their research contributions span 582 publications in Medicine, including significant work in related subfields such as Neurology, Pathology and Forensic Medicine, Immunology, Oncology, and Molecular Biology.

Their work notably addresses various neurological and immunological disorders. Key research topics include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Polyomavirus and related diseases
  • Peripheral Nerve Disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Myasthenia Gravis and Thymoma

Ralf Gold has published extensively in several major scientific venues, with frequent publications appearing in:

  • Neurology
  • Therapeutic Advances in Neurological Disorders
  • Journal of Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Multiple Sclerosis Journal

Collaboration forms a significant part of Ralf Gold's research efforts. Regular co-authors include Jeremias Motte, Kalliopi Pitarokoili, Anna Lena Fisse, Simon Faissner, and Thomas Grüter, with numerous shared publications.

Representative recent papers authored or co-authored by Ralf Gold are:

  • "Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism," 2020, Cell
  • "Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism," 2021, European Heart Journal
  • "Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)," 2021, Therapeutic Advances in Neurological Disorders
  • "Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management," 2023, Journal of Neurology
  • "Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders," 2021, Neurology Neuroimmunology & Neuroinflammation

Best Publications

  • Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

    Ralf Gold;Christopher Linington;Hans Lassmann

  • Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques.

    R Gold;M Schmied;G Giegerich;H Breitschopf

  • Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

    Harald H. Hofstetter;Saleh M. Ibrahim;Dirk Koczan;Niels Kruse

  • CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation

    Ralf A. Linker;Mathias Mäurer;Stefanie Gaupp;Rudolf Martini

  • Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

    Marco Prinz;Marco Prinz;Hauke Schmidt;Alexander Mildner;Alexander Mildner;Klaus-Peter Knobeloch

  • Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.

    M Schmied;H Breitschopf;R Gold;H Zischler

  • Animal models for autoimmune demyelinating disorders of the nervous system

    Ralf Gold;Hans-Peter Hartung;Klaus V Toyka

  • Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections.

    R Gold;M Schmied;G Rothe;H Zischler

  • Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration.

    S. Schilling;S. Goelz;R. Linker;F. Luehder

  • Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin

    Claudia Sommer;Andreas Weishaupt;Jörg Brinkhoff;Lydia Biko

  • Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

    Maria Isabel Leite;Philipp Ströbel;Margaret Jones;Kingsley Micklem

  • Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

    H. Wiendl;K. V. Toyka;P. Rieckmann;R. Gold

  • Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

    Hannelore Ehrenreich;Benjamin Fischer;Christine Norra;Felix Schellenberger

  • Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

    Niklas Beyersdorf;Stefanie Gaupp;Karen Balbach;Jens Schmidt

  • Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.

    Bernd C. Kieseier;Reinhard Kiefer;Ralf Gold;Bernhard Hemmer

  • Plasma exchange for severe optic neuritis: treatment of 10 patients.

    K. Ruprecht;E. Klinker;T. Dintelmann;P. Rieckmann

  • Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis

    J. Zielasek;S. Jung;R. Gold;F.Y. Liew

  • Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation

    Tim Magnus;Andrew Chan;Oliver Grauer;Klaus V. Toyka

  • Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders.

    Ralf Gold;Frank Buttgereit;Klaus V Toyka

  • Immune Deficiency in Mouse Models for Inherited Peripheral Neuropathies Leads to Improved Myelin Maintenance

    Christoph D. Schmid;Martina Stienekemeier;Stephan Oehen;Frank Bootz

Frequent Co-Authors

Klaus V. Toyka
Klaus V. Toyka University of Würzburg
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Hans Lassmann
Hans Lassmann Medical University of Vienna
Andrew T. Chan
Andrew T. Chan Harvard University
Hartmut Wekerle
Hartmut Wekerle Max Planck Society
Christopher Linington
Christopher Linington University of Glasgow
Michael Sendtner
Michael Sendtner University of Würzburg
Fred Lühder
Fred Lühder University of Göttingen
Thomas Hünig
Thomas Hünig University of Würzburg
Clemens R. Müller
Clemens R. Müller University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers, often requiring specialized education pathways. For those interested in advancing clinical skills, exploring an accelerated nurse practitioner program can be a fast track to becoming a Nurse Practitioner, integrating immunological knowledge with patient care.

Nurses seeking a transition into more acute and specialized settings may consider acute care nurse practitioner programs, which focus on high-acuity patient populations. This path leverages a background in Immunology to provide expert care in critical care environments.

For those starting fresh in nursing, online options like online ADN programs for non nurses offer foundational education accessible from anywhere. These programs set the stage for advanced studies in Immunology-related health fields.

Salary potential varies by specialty and location, which is crucial when planning your career. The dnp salary by specialty resource provides valuable insights to help you align your educational and professional goals with market demand.

Best Scientists Citing Ralf Gold

Trending Scientists

Recently Published Articles